Capital Research Global Investors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1422848
Los Angeles, CA
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,433,587,964
+$1,583,050,249 QoQ
Shares Held
21,125,964
+22.0% QoQ
Ownership
8.32%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 99.87758191768195.ToString("F0")%
Shared 0.ToString("F0")%
None 0.12241808231804238.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $13,789,933,930 across 16 Biotechnology names. VRTX ranks #1 (68.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
21,125,964 | $9,433,587,964 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,471,181 | $3,133,729,657 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,491,386 | $197,228,395 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
5,163,543 | $172,049,252 | |
| 5 | TECH |
BIO-TECHNE Corp
|
3,188,210 | $166,615,854 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
1,673,275 | $139,367,074 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
11,191,116 | $100,831,955 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,115,460 | $97,011,556 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,433,587,964 | 21,125,964 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,850,537,715 | 17,316,344 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,482,926,970 | 16,553,281 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,171,411,153 | 16,108,291 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,047,510,298 | 14,536,344 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,199,738,567 | 10,428,951 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,186,745,501 | 9,002,205 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,002,558,976 | 8,539,339 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,401,000,114 | 5,743,882 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,451,646,804 | 3,567,664 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,172,782,360 | 3,372,584 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,077,434,401 | 3,061,676 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $255,173,617 | 809,895 | Shares | Defined | 2023-05-15 | |
| 2020-09-30 | $340,329,054 | 1,250,658 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $363,078,814 | 1,250,659 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $297,595,498 | 1,250,664 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||